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Objectives. To review the literature regarding ileovesicostomy and evaluate our patient population for clinical characteristics.
Methods. Various surgical reconstructive techniques allow management of diﬃcult clinical scenarios involving patients with
neurogenic bladder, irretraceable lower urinary tract symptoms, lower urinary tract disaster, and urethrocutaneous ﬁstulae. One
such reconstructive technique employed is the ileovesicostomy. This procedure provides patients with a low-pressure urinary
conduit utilizing the ileum and native bladder that empties without catheterization. We describe our patient population who
underwent ileovesicostomy for 5 consecutive years ending 2007 at Detroit Receiving Hospital. Results. Most common diagnosis
was neurogenic bladder secondary to spinal cord injury. Our population and clinical outcomes are similar to those previously
reported in the literature. Conclusions. Based on our experience, we suggest that patients with severe lower urinary tract symptoms
and who are unable to perform clean intermittent catheterization and/or refractory to medical therapy ileovesicostomy should be
the procedure of choice.
Copyright © 2009 W. B. Zimmerman and R. A. Santucci. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
In the 21st century, various surgical reconstructive tech-
niques allow management of diﬃcult clinical scenarios
involving neurogenic bladder, intractable lower urinary tract
obstruction, and lower urinary tract disasters such as some-
times occur after prostate cancer treatments. As a method in
dealing with the worst of these problems, suprapubic diver-
sionhasprogressedsigniﬁcantlyoverthepast50years.Inthe
1950s, cutaneous vesicostomy evolved into ileocystostomy
(which is now called ileovesicostomy), which improved
the location and quality of the stoma, allowing improved
patientsdryness[1,2].Duringthelate1900s,cystectomyand
ilealloopalsobecamecommon,butlikelyisanunnecessarily
invasive treatment for many patients nowadays. From the
1960s to 1980s, ileal loop diversion and chronic indwelling
urethral catheterization were the mainstays of therapy. In
the 1970s, clean intermittent self-catheterization (CIC) [3]
took the forefront, but more complex techniques such as
ileovesicostomy are still commonly necessary in special or
refractory cases.
2. History
Smith and Hinman ﬁrst described ileovesicostomy in 1955,
using dogs and anastomosing ileum to the native bladder in
situ.Thisallowedthebladdertoactasa“continentreservoir,”
which was drained volitionally through the ileal conduit
instead of the urethra. They postulated that the bladder
neck continence mechanism would remain, and that voiding
would occur through the subject’s own detrusor contraction
[1]. Of course, in humans, ileovesicostomy is designed as a
completely incontinent suprapubic diversion.
In 1957, Cordonnier described a case series of three
successive patients on whom he utilized an “ileocystostomy”
(aka “ileovesicostomy”) for neurogenic bladder in children
suﬀering from meningomyelocele. In Cordonnier’s mod-
iﬁcation, the ileum was anastomosed to the bladder in
a peristaltic fashion, and the urine was collected in a
rudimentary urostomy bag [2].
In more recent years, multiple authors have reported
that the ileovesicostomy procedure provides an easily emp-
tying and noncatheterizable low-pressure urinary conduit2 Advances in Urology
[4–7]. With ileovesicostomy, the primary objectives include
establishing a vesical diversion that has a low detrusor
leak point pressure (as low as 8cm in some series) and
minimalcomplications,thusallowingsafe,lifelong,catheter-
free bladder drainage [4].
3. Indications
There are four major reasons to consider an ileovesicostomy
in the modern day.
(1) Neurogenic bladder patients, who wish to avoid the
long-term complications of chronic suprapubic or
urethral catheter drainage, yet are unable or unwill-
ing to use CIC or a continent diversion such as a
continent catheterizable stoma (e.g., Mitrofanoﬀ or
Monti procedure). Ileovesicostomy may be especially
indicated in those patients that also need a bladder
neck closure, as patient and surgeon prefer the more
reliable urinary egress provided by ileovesicostomy
over Mitrofanoﬀ, which has nearly a high chance of
requiring eventual surgical revision [8].
(2) Cases of intractable lower urinary tract obstruction,
such as bladder neck contracture, in a patient who is
unable or unwilling to have an alternative suprapubic
diversion (e.g., suprapubic tube or Mitrofanoﬀ).
(3) Lower urinary tract disaster that may be caused by
radiation therapy for prostate cancer (e.g., urethral
stricture,and/orurethral-rectalﬁstula,and/orincon-
tinence, and/or a small capacity bladder).
(4) Urethrocutaneous ﬁstula into a decubitus ulcer in a
spinal cord injury patient [9].
4. Performance Characteristics of
Ileovesicostomy for Neurogenic Bladder
McGuire and associates [10] reported that ileovesicostomy
maintains a detrusor leak point pressure less than 40cm
of water and preserves upper tract function as well or
better than the traditional treatments of anticholinergic
medications and CIC. However, this patient population was
“self-selected” as they generally chose to abandon CIC either
by choice or through lack of home care support. In a long-
term study, Leng reported that yearly measures of detrusor
leak point pressure less than 40cm of water were achieved in
the 38 of 41 of these patients (93%) [11].
In a large series of ileovesicostomy patients with neuro-
genicbladder,Schwartzetal.[12]reportedin23patientsthat
the creation of low-pressure urine collection system could
eliminatetheassociatedproblemswithurinaryincontinence,
that is, infection, calculi, and urethrocutaneous ﬁstulae. The
authorsassertedthatpreservationofthenativevesicoureteral
junction and neurologic urinary function could be attained
with an ileovesicostomy, but not with cystectomy and ileal
loop. The surgical morbidity associated with cystectomy
is avoided, and it is technically easier to perform. The
ileovesicostomy has the additional advantage of utilizing
the native trigone hence maintaining the native ureter’s
nonreﬂuxing mechanism [12].
Rivas and associates described the cutaneous ileocys-
tostomy or “bladder chimney” in the treatment of severe
neurogenic vesical dysfunction. Their results indicated that
this procedure was a valid alternative for patients with “a
bladder capacity less than or equal to 200mL, recurrent
febrile urinary tract infection, and urinary incontinence
despite an indwelling urethral catheter.” In the 11 patients
studied, the need for long-term urinary catheterization
was eliminated with eﬀective low-pressure urinary stomal
drainage [13].
5. Indications for the Ileovesicostomy for
Neurogenic Bladder
In the neurogenic bladder patient who is unable to store
urine, Elliot and associates indicated that medical therapy
was considered ﬁrst treatment. Among surgical treatments,
the “gold standard” operations included supravesical diver-
sion or augmentation cystoplasty [14]. Ileovesicostomy may
beparticularlyusefulinthosewithpoorbladdercompliance.
It is known that a poorly compliant bladder can develop in
about 10% percent of patient with suprasacral spinal cord
injuries and 50% with sacral level injuries [4]. With spinal
cord injury, a correlation exists with upper tract complica-
tions and poor bladder compliance. This has been associated
with radiographic upper tract abnormality, vesicoureteral
reﬂux,pyelonephritis,anduppertractstones[4,15].Reliable
low-pressure egress of urine without the need for catheters
provided by the ileovesicostomy is an ideal answer to this
problem.
Older series often advocate the wide use of cystectomy
and ileal conduit to treat neurogenic bladder. However,
cystectomy is unnecessarily morbid and is made largely
unnecessary by the ileovesicostomy operation. Also, the
lifetime risk of ureteroileal obstruction after cystectomy
is higher than most want to admit—a complication that
is avoided with ileovesicostomy. Recently, in a cohort of
553 cystectomy patients, Msezane and associates report a
ureteral anastomosis stricture rate of 7% [16]. We reserve
cystectomy/ileal loop only in those patients who have a
completelyacontractilebladder(inwhichanileovesicostomy
is thought to empty poorly by some experts) or in those with
other bladder pathology requiring bladder removal (ﬁstula,
etc.) [5, 12].
6. Outcomes/Complications of Ileovesicostomy
In 1994, Schwartz and associates reported 23 patients who
underwent ileovesicostomy. Of these cases, 17 patients were
quadriplegic, ﬁve had lower spinal cord abnormalities, and
one patient had a “watering pot perineum.” They reported
a mean followup of 45 months. Twenty-one of 23 (91%)
patients had egress of urine at bladder pressure less than
20cm of water. Early complications included pneumonia,
bladderoutletobstruction,poordrainage,andincreasedleakAdvances in Urology 3
point pressure. Late complications included stomal stenosis,
parastomal hernia, and detrusor hyperreﬂexia [12].
In a quadriplegic population, Mutchnik and associates
reported six consecutive male patients who underwent
ileovesicostomy for bladder management. The majority of
patients reported being displeased with current bladder
regimens that included CIC in two patients, suprapubic
catheter in three patients, and urethral catheter in one.
Overall, patients did well, but the best outcomes were
seen in patients with low (<100mL) preoperative urine
residuals. Complications were relatively uncommon: one
patient (17%) had a urinary tract infection, associated with
a postoperative residual volume greater than 100mL, while
one (17%) had continued urethral urine leakage and was
managed successfully with perineal closure of the urethra.
In 1999, Gudziak et al. [5] reported their experience
of 13 patients which had undergone incontinent ileovesi-
costomy. Preoperatively, their patient population suﬀered
chronic urinary tract infections, incontinence, or urethral
erosion. The mean followup was 23 months. Fourteen
concomitant procedures were preformed in 11 patients
and four complications were identiﬁed including stomal
stenosis (7%), wound infection (7%), and two patients
with ileus (15%) which resolved spontaneously. There was
improvement in vesicoureteral reﬂux, and mean detrusor
leak point pressures dropped to an average of 8cm of water.
No associated mortality was seen, and no patients developed
renal insuﬃciency postoperatively [5].
Tan et al. [17] reported their experience of 50 patients
whohadundergoneileovesicostomywithameanfollowupof
26 months. Their patient population primarily consisted of
neurogenic bladder cases with 21 patients having spinal cord
injuries and 19 patients having multiple sclerosis. Eighty-
eight percent had preoperative incontinence despite conser-
vative bladder management, with 37 patients (74%) having
indwelling urethral and/or suprapubic catheter drainage
devices. Thirty-nine concomitant procedures were per-
formed,usuallycystotomyclosures.Theincidenceofurinary
tract comorbidities decreased from 3.4 per patient per year
to 1.2 per patient per year. Continence was achieved in
36 (72%) patients. Twenty-eight stoma complications were
noted in 19 patients: 14 ill-ﬁtting appliance, eight stomal
stenosis, three ulcerations, two retractions, and one hernia.
Twenty-three mechanical complications were noted in 11
patients primarily related to ileovesicostomy obstruction
(12%), stomal stenosis (12%), ileal-kinking secondary to
redundancy (10%), mucus plugging (8%), and ileovesi-
costomy stricture (4%) (Table 1). Interestingly, reoperation
of 77 procedures occurred in 27 patients ranging from
ileovesicostomy revisions to urethral closure procedures.
There was no associated mortality within the ﬁrst 12 months
[17].
Overall, various authors have reported their compli-
cations associated with ileovesicostomy. These outcomes
range as follows: urethral incontinence rates (16–88%),
urinary tract infection (16%), urinary ﬁstula (32%), wound
infection (7–34%), hematuria (18%), stomal stenosis (7–
16%), ileovesicostomy obstruction (12%), fascial stenosis
(12%), and small bowel obstruction/ileus (15%).
7. Laparoscopic Ileovesicostomy
As the world of minimally invasive surgery has grown, the
attempt to perform ileovesicostomy via the laparoscopic
approach is evolving. The proposed beneﬁts for laparo-
scopicapproachincludecomparableoperativetime,decrease
in blood loss, and decreased postoperative convalescence.
Currently, there are two case reports in humans describing
laparoscopic ileovesicostomy. The ﬁrst case was performed
in 240 minutes and blood loss of 100mL. The patient had
an uneventful postoperative course and was discharged on
hospital day four [18]. The second case study described the
ﬁrst successful pure laparoscopic approach performed in 270
minutes and an estimated blood loss of 50mL [19].
8.PredictingtheNeedforBladderNeckClosure
In performing an ileovesicostomy, the question will arise as
whether to routinely close the bladder neck in order to ﬁx
continued urinary incontinence from the patient’s urethra.
The literature does not readily identify patients that would
beneﬁt from this procedure. Usually we do not perform
urethral/bladder neck closure at the time of ileovesicostomy
unless we have objective evidence that it is required (such
as a patient with a pre-existing suprapubic tube who has
persistent total incontinence through the urethra). Only one
study addressed this issue in patients with ileovesicostomy
for neurogenic bladder; Mutchnik had one patient (17%)
who subsequently required bladder neck closure secondary
to persistent urethral leakage. Another author reported no
patients in their series of 13 patients, who required bladder
neck closure [5]. However, patients who are treated for
urethral destruction have a high rate of requiring subsequent
urethral closure (perhaps because the urethral destruction
is associated with concomitant bladder neck destruction).
In addition, Schwartz et al. provide some helpful guidance,
as they performed bladder neck closure at the time of
ileovesicostomy in women patients when ﬂuorourodynamic
studies demonstrated poor proximal urethral function.
9.DetroitReceivingHospitalExperience
After approval by the Human Investigations Committee
at Wayne State University, we evaluated our patients who
had undergone ileovesicostomy to characterize the com-
mon complications following the procedure and determine
success rates. Patients were included if 18 years of age or
older and had undergone an ileovesicostomy for a ﬁve-year
periodendingSeptember2007atDetroitReceivingHospital.
Patients were treated according to our algorithm (Figure 1).
Extraction of patient information from the surgeon’s
procedural logs from the prescribed time period yielded
eight patients: 5 men and 3 women. The mean age was 33
years (range 25–37). The mean weight and BMI was 65 ±
22kg and 25 ± 8kg/m 2, respectively. Patients had an average
lengthofstayof12days,howeversomepatientshadmultiple
combined general and urological surgical procedures which
extended their stay. All patients discharged to home with
the exception of one patient who returned to an extended4 Advances in Urology
Table 1: Comparison of complications.
Author Year N Indication Complications
Schwartz et al. [12] 1994 23
SCI, MS, CP,
myelomeningocele
Early: pneumonia, bladder
outlet obstruction, increased
LPP
Late: stomal stenosis,
parastomal hernia, detrusor
hyperreﬂexia
Mutchnik et al. [6] 1997 6 SCI UTI, urethral urine leakage,
urinary retention
Gudziak et al. [5] 1999 13
SCI, MS,
tuberculosis
meningitis
Stomal stenosis, wound
infection, ileus, vesicovaginal
ﬁstula
Leng et al. [11] 1999 38 SCI, infracervical
SCI, MS, other
Early: stomal stenosis,
dysreﬂexia, wound infection,
stomal prolapse/stenosis, SBO
Late: renal and bladder calculi,
retracting stoma, UTI, fascial
stenosis, ileal limb kink,
stricture
Tan et al. [17] 2008 50
SCI, MS, spina
biﬁda, radical
retropubic
prostatectomy
Stomal complications
(stenosis, ulcerations,
retractions, hernia),
obstruction, stomal stenosis,
ileal-kinking, mucus plugging,
stricture, wound infections,
SBO/ileus, wound
dehiscence/evisceration,
intra-abdominal abscess,
hernia
Zimmerman 8 SCI, ﬁstula UTI, wound dehiscence,
blood stream infection, ileus
SCI: spinal cord injury, MS: multiple sclerosis, UTI: urinary tract infection, SBO: small bowel obstruction, CP: cerebral palsy, LPP: leak point pressure.
care facility. In this urban population, substance abuse
was common: 75% tobacco use, 50% ethanol use, and
50% recreational drugs use. The most common diagnosis
for surgical consideration was neurogenic bladder with
persistent urine leakage (Table 2).
The primary etiology in our patients was spinal cord
injury in seven, ﬁve as a result from complications of gun
shot wounds. The others were a wrestling injury and a
diving injury. One patient was classiﬁed as a quadriplegic
and six were paraplegic. The eighth patient suﬀered from
total urinary incontinence as a result from cervical cancer
andhadpreviouslyunderwenttotalabdominalhysterectomy
and bilateral salpingoophrectomy followed by radiation to
the pelvis.
Preoperatively, the majority of our patients were man-
aged with urethral catheters. Other techniques were also
employed: CIC, incontinence pads, chronic suprapubic
catheterization, and failed enterocystoplasty with Mitro-
fanoﬀ appendicovesicostomy. Followup was possible in 7 of
8 patients; all were alive and well postprocedure.
A total of six complications were identiﬁed in eight
patients. Complications associated with our ileovesicostomy
patient population included one urinary tract infection
(16%), one wound dehiscence (16%), one blood stream
infection (16%), and two patients who developed tempo-
rary ileus (32%). One patient (16%) with a history of
total incontinence secondary to high-dose cervical radiation
therapy developed a rectovaginal and vesicourethral ﬁstula
after the ileovesicostomy procedure. Although Tan et al.
[17] reported signiﬁcant reoperation rates, our experience
demonstratesmuchlowerreoperativeandcomplicationrates
(Table 2).
10. Ileovesicostomy Avoids the Many Potential
Complications of ChronicCatheterization
Ileovesicostomy serves as an alternative in those patients
with chronic outlet obstruction who have failed conser-
vative management. The expected complication rate from
ileovesicostomy is enumerated previously in this paper. The
complications of chronic urethral or suprapubic catheter-
ization are well known, but harder to quantify in the
literature. Schwartz et al. reported 30% patients with pro-
gressive incontinence or urethrocutaneous ﬁstulas, 39% with
urosepsis, 39% with recurrent upper and/or lower tract
urolithaisis, 13% had autonomic dysreﬂexia, and 17% had
worsening hydronephrosis and/or ureteral reﬂux [12]. InAdvances in Urology 5
Neurogenic
bladder
Medication +
CIC
Continued medical
management +
yearly UDS
Medical refractory
or
DLPP elevated
Unwilling/unable
to perform CIC
Indwelling
catheter
Contractile
bladder
Refractory,
complicated
Acontractile
bladder
Proceed to
ileovesicostomy versus
cystectomy w/ ileal
loop w/ caution
Ileovesicostomy
UDS
CIC: Clean intermittent catheterization
DLPP: Detrusor leak point pressure
UDS: Urodynamic study
Figure 1: Decision tree for the management of neurogenic bladder.
Table 2: Patient characteristics.
Patient no.
(Age, years)
Sex Etiology Preoperative
management (years)
Followup
(months)
Concomitant surgery Reoperative procedure
1 (27) M SCI (C6) Chronic urethral
catheter (3)
Unable to
contact
None None
2 (33) M SCI (T11) CIC (14), chronic
urethral catheter (1) 45.1 None None
3 (41) F
Vesicovaginal
ﬁstula, history of
cervical CA with
hysterectomy and
radiation
Incontinence pads 6 Urethral closure Vaginoscopy, cystogram,
vaginogram
4 (34) M SCI (T10) CIC (1) 26.6 None
Reop 1: urinary ﬁstula
closure, urethral closure
Reop 2:
enterocystoplasty,
Mitrofanoﬀ,b l a d d e r
neck closure
5 (27) M SCI (T10) SP catheter, CIC (2) 38.9 None None
6 (37) F SCI (T3)
Cystoplasty, Monti
catheterizable stoma,
cystoscopy with urethral
bulking agent injection
(24)
Failed to
return to
clinic
Urethral closure None
7 (25) M SCI (T3) Chronic urethral
catheter (2) 1.7 Gastrocutaneous ﬁstula repair Urethral bulking agent
injection
8 (37) F SCI (T4) SP catheter (12) 36.6 SP tube closure None
M: male, F: female, SCI: spinal cord injury, C: cervical, T: thoracic, CA: cancer, CIC: clean intermittent catheterization , SP: suprapubic, Reop: Reoperation.
a related article, Larsen et al. reported 49 of 56 (88%) of
urethrally catheterized patients experienced a total of 202
complicationsincludingrenaldamage,UTIs,stones,urethral
erosions, strictures, abscesses, and 2 deaths associated to
urosepsis [20].
Patients with suprapubic catheters were noted to have
complications too. In the preanticholinergic era, patients
with suprapubic tubes appeared to suﬀer renal deterio-
ration equivalent to 20 years of urethral catheterization,
but after only 5 years time [21]. Probably, modern use of6 Advances in Urology
anticholinergics has improved upper tract protection [22].
Finally, urothelial malignancy is a dreaded complication of
prolonged urinary catheterization. In the Department of
Veterans Aﬀairs study, chronic catheterization led to bladder
cancer in 0.4% of patients [23].
Upper tract deterioration is another complication of
chronic catheterization that might be avoided with ileovesi-
costomy. Ku et al. report an incidence of upper tract
deterioration in 52% and 26%, pyelonephritis in 41%
and 31%, and renal stones in 21% and 36% of patients
with SCI managed with urethral catheter, and suprapubic
catheterrespectively.Thiswasalong-termstudywithamean
followupof 25.2 years[24].The r ealsoap pear st obeagr eat e r
incidence of bladder calculus formation in patients with a
urethral catheter as compared to suprapubic cystotomy [25].
11. Conclusions
Currently, debate exists amongst practitioners regarding
neurogenic bladder patients where ileovesicostomy should
be placed in the algorithm for treatment. The current
practice standard is trial of management with CIC, followed
by indwelling urinary catheter (urethral versus suprapubic
cystotomy), and later, operative maneuvers to eliminate the
chronic catheter altogether. Operative intervention consists
of cystectomy with ileal diversion, augmentation cystoplasty
with or without appendicovesicostomy, or ileovesicostomy.
Multiple authors have suggested that in patients with severe
lower urinary tract symptoms and who are unable to
perform CIC and/or refractory to medical therapy, ileovesi-
costomy should be the procedure of choice. In light of
the known complications associated with chronic indwelling
urinary catheters, we have found this procedure beneﬁcial,
as well as easy to perform, generally successful, and durable.
Postoperative or intraoperative closure of the incompetent
bladder neck might sometimes also be required in the
ileovesicostomy patient.
Abbreviations
BMI: Body mass index
CIC: Clean intermittent catheterization
DLPP: Detrusor leak point pressure
SCI: Spinal cord injury
UTI: Urinary tract infection.
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